Since the beginning of the 21st century, organocatalysts have established themselves as a third group of homogeneous catalysts, next to biocatalysts (enzymes) and transition-metal based catalysts . In particular enantioselective organocatalysis has shown an impressive rise in the last decades, owing to the tunability of catalysts and different modes of activation, enabling a manifold of different transformations . The development of the field, driven by many researchers, led to the award of the Nobel Prize to List and MacMillan in 2021 'for the development of asymmetric organocatalysis'. Organocatalytic transformations have also seen the transition to industrial processes for the production of a variety of pesticides and medicinal compounds, as recently reviewed .